Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Economic crisis-related increased suicidality in Greece and Italy: a premature overinterpretation..
J Epidemiol Community Health. 67(4), 379-80.
(2013). The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorder..
Curr Pharm Des. 18(12), 1605-8.
(2012). The Role of Temperament in the Etiopathogenesis of Bipolar Spectrum Illness..
Harv Rev Psychiatry. 24(1), 36-52.
(2016).
(2014). Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer..
ESMO Open. 4(2), e000474.
(2019). A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer..
Cancer Chemother Pharmacol. 65(4), 649-60.
(2010). Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation..
Anticancer Res. 31(9), 3007-18.
(2011). Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial..
PLoS One. 8(7), e69256.
(2013). Disease evolution and heterogeneity in bilateral breast cancer..
Am J Cancer Res. 6(11), 2611-2630.
(2016). A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study..
Breast Cancer Res Treat. 115(1), 87-99.
(2009). Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer..
PLoS One. 8(8), e70429.
(2013). Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe..
Int J Cancer. 142(1), 66-80.
(2018). Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer..
Ann Oncol. 23(8), 2146-53.
(2012). Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities..
J Glob Oncol. 4, 1-12.
(2018). Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative..
Oncotarget. 11(1), 1-14.
(2020). HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy..
J Transl Med. 10, 10.
(2012). Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab..
J Transl Med. 10, 212.
(2012). MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer..
J Oncol. 2009, 305908.
(2009). Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck..
Anticancer Res. 29(2), 529-38.
(2009).
(2013). TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting..
Oncotarget. 7(22), 32731-53.
(2016). Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel..
PLoS One. 7(6), e37946.
(2012). Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer..
Oncotarget. 9(86), 35623-35638.
(2018). Hepatic Artery Anatomic Variations and Reconstruction in Liver Grafts Procured in Greece: The Effect on Hepatic Artery Thrombosis..
Transplant Proc. 51(2), 416-420.
(2019). [Face rehabilitation for post-burn deformities]..
Ann Chir Plast Esthet. 56(5), 388-407.
(2011).